MiR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  Yu, Jun Jie ^a   Wu, Yin Xia ^b   Zhao, Fu Jun ^a   Xia, Shu Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

FOXO1; miR 96; Proliferation; Prostate cancer

Indexed keywords

MICRORNA; MICRORNA 96; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; MIRN96 MICRORNA, HUMAN;

AGED; APOPTOSIS; ARTICLE; CANCER CELL; CASE REPORT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; DOWN REGULATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL CYCLE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSTATE TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

AGED; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84898828496     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0910-y     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106-30.
2. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7(4):256-69. doi: 10.1038/nrc2090.
3. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848-56. doi: 10.1200/jco.2009.24.0317.
4. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008;27(31):4373-9. doi: 10.1038/onc.2008.72.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
6. Shi XB, Tepper CG, deVere White RW. Cancerous miRNAs and their regulation. Cell Cycle. 2008;7(11):1529-38.
7. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-69. doi: 10.1038/nrc1840.
8. Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res. 2012;72(16):4037-46. doi: 10.1158/0008-5472.CAN-12-0103.
9. Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, Erbersdobler A, et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem. 2010;56(6):998-1006. doi: 10.1373/clinchem.2009.141580.
10. Pang Y, Young CYF, Yuan H. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin. 2010;42(6):363-9. doi: 10.1093/abbs/gmq038.
11. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, Bevan CL. Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet. 2012;. doi: 10.1093/hmg/dds139.
12. Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, et al. miR-21: an oncomir on strike in prostate cancer. Mol Cancer. 2010;9:12. doi: 10.1186/1476-4598-9-12.
13. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, Giangreco AA, et al. miR-183-96-182 Cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem. 2011;286(52):44503-11. doi: 10.1074/jbc.M111.262915.
14. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126(5):1166-76. doi: 10.1002/ijc.24827.
15. Larne O, Martens-Uzunova E, Hagman Z, Edsjo A, Lippolis G, den Berg MS, et al. miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer. 2013;132(12):2867-75. doi: 10.1002/ijc.27973.
16. Kang SG, Ha YR, Kim SJ, Kang SH, Park HS, Lee JG, et al. Do microRNA 96, 145 and 221 expressions really aid in the prognosis of prostate carcinoma? Asian J Androl. 2012;14(5):752-7. doi: 10.1038/aja.2012.68.
17. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24(50):7410-25. doi: 10.1038/sj.onc.1209086.
18. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120(Pt 15):2479-87. doi: 10.1242/jcs.001222.
19. Li R, Erdamar S, Dai H, Wheeler TM, Frolov A, Scardino PT, et al. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. Hum Pathol. 2007;38(10):1501-7. doi: 10.1016/j.humpath.2007.02.016.
20. Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, et al. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 2006;66(14):6998-7006. doi: 10.1158/0008-5472.CAN-06-0411.
21. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 2010;70(1):367-77. doi: 10.1158/0008-5472.can-09-1891.
22. Zhou L, Yin B, Liu Y, Hong Y, Zhang C, Fan J. Mechanism and function of decreased FOXO1 in renal cell carcinoma. J Surg Oncol. 2012;105(8):841-7. doi: 10.1002/jso.23013.
23. Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, et al. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 2011;71(9):3257-67. doi: 10.1158/0008-5472.can-10-2603.
24. Wu Z, Sun H, Zeng W, He J, Mao X. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS ONE. 2012;7(9):e45825. doi: 10.1371/journal.pone.0045825.
25. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284(35):23204-16. doi: 10.1074/jbc.M109.031427.
26. Wu Z, He B, He J, Mao X. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate. 2012;. doi: 10.1002/pros.22600.
27. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 2010;70(1):367-77. doi: 10.1158/0008-5472.CAN-09-1891.
28. Guo Y, Liu H, Zhang H, Shang C, Song Y. miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer. Oncol Lett. 2012;4(3):561-5. doi: 10.3892/ol.2012.775.